• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低血管性血友病因子诊断标准及预测未来出血的风险评分

Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding.

作者信息

Atiq Ferdows, Wuijster Esmee, de Maat Moniek P M, Kruip Marieke J H A, Cnossen Marjon H, Leebeek Frank W G

机构信息

Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Department of Pediatric Hematology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

J Thromb Haemost. 2021 Mar;19(3):719-731. doi: 10.1111/jth.15227. Epub 2021 Jan 24.

DOI:10.1111/jth.15227
PMID:33370487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7986755/
Abstract

BACKGROUND

Important diagnostic and clinical aspects of moderately reduced von Willebrand factor (VWF) levels are still unknown. There is no clear evidence which cutoff value (0.50 vs 0.60 IU/ml) should be used to diagnose "low VWF." Also, the incidence of bleeding after the diagnosis has been made, and risk factors for bleeding are unknown yet.

OBJECTIVES

To investigate the incidence of postsurgical bleeding, postpartum hemorrhage (PPH), and traumatic and spontaneous bleeding after low VWF diagnosis, and to develop a risk score to predict future bleeding.

METHODS

We performed a cohort study in patients with historically lowest VWF levels of 0.31 to 0.60 IU/ml. Clinical data of patients were retrospectively collected.

RESULTS

We included 439 patients with low VWF. During a follow-up of 6.3 ± 3.7 years, 259 surgical procedures, 81 deliveries, and 109 spontaneous and traumatic bleeding episodes were reported. The incidence of postsurgical bleeding was 2.7%, whereas 10% of deliveries was complicated by PPH. Overall, 65 patients (14.8%) had bleeding requiring treatment, which was not different between patients with historically lowest VWF levels of 0.31-0.50 and 0.51-0.60 IU/ml (p = .154). Age <18 years, abnormal bleeding score at diagnosis, and being referred for bleeding symptoms at the time of diagnosis were independent risk factors for bleeding during follow-up, and therefore included in the risk score.

CONCLUSIONS

The cutoff value of low VWF diagnosis should be set at 0.60 IU/ml. Furthermore, a risk score is developed to identify individuals with a high risk for bleeding after low VWF diagnosis.

摘要

背景

血管性血友病因子(VWF)水平中度降低的重要诊断和临床方面仍不清楚。尚无明确证据表明应使用哪个临界值(0.50 与 0.60 IU/ml)来诊断“低 VWF”。此外,诊断后出血的发生率以及出血的危险因素尚不清楚。

目的

调查低 VWF 诊断后手术出血、产后出血(PPH)以及创伤性和自发性出血的发生率,并制定一个风险评分来预测未来出血情况。

方法

我们对历史上 VWF 水平最低为 0.31 至 0.60 IU/ml 的患者进行了一项队列研究。回顾性收集患者的临床资料。

结果

我们纳入了 439 例低 VWF 患者。在 6.3±3.7 年的随访期间,报告了 259 例外科手术、81 例分娩以及 109 例自发性和创伤性出血事件。手术出血的发生率为 2.7%,而 10%的分娩并发 PPH。总体而言,65 例患者(14.8%)发生了需要治疗的出血,历史上 VWF 水平最低为 0.31 - 0.50 和 0.51 - 0.60 IU/ml 的患者之间无差异(p = 0.154)。年龄<18 岁、诊断时异常出血评分以及诊断时因出血症状转诊是随访期间出血的独立危险因素,因此纳入风险评分。

结论

低 VWF 诊断的临界值应设定为 0.60 IU/ml。此外,制定了一个风险评分来识别低 VWF 诊断后出血风险高的个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/99314e3a2202/JTH-19-719-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/820dfc681b8e/JTH-19-719-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/a46caaa14875/JTH-19-719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/99819116dd21/JTH-19-719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/99314e3a2202/JTH-19-719-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/820dfc681b8e/JTH-19-719-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/a46caaa14875/JTH-19-719-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/99819116dd21/JTH-19-719-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df67/7986755/99314e3a2202/JTH-19-719-g004.jpg

相似文献

1
Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding.低血管性血友病因子诊断标准及预测未来出血的风险评分
J Thromb Haemost. 2021 Mar;19(3):719-731. doi: 10.1111/jth.15227. Epub 2021 Jan 24.
2
Clinical significance of slightly reduced von Willebrand factor activity.血管性血友病因子活性轻度降低的临床意义。
Pol Arch Intern Med. 2020 Mar 27;130(3):225-231. doi: 10.20452/pamw.15162. Epub 2020 Jan 28.
3
Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease.成年中重度血管性血友病患者出血表型的决定因素。
Thromb Haemost. 2012 Oct;108(4):683-92. doi: 10.1160/TH12-04-0244. Epub 2012 Aug 23.
4
Bleeding Symptoms and von Willebrand Factor Levels: 30-Year Experience in a Tertiary Care Center.出血症状和血管性血友病因子水平:一家三级护理中心 30 年的经验。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619866916. doi: 10.1177/1076029619866916.
5
The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease.1型血管性血友病中衰老与血管性血友病因子水平及出血风险的关联
Clin Appl Thromb Hemost. 2018 Apr;24(3):434-438. doi: 10.1177/1076029617724232. Epub 2017 Sep 6.
6
Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels.边缘型血管性血友病因子血浆水平个体中血管性血友病诊断的预测因子。
J Thromb Haemost. 2015 Feb;13(2):228-36. doi: 10.1111/jth.12799. Epub 2015 Jan 9.
7
von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.血管性血友病因子水平在血管性血友病诊断中的作用:系统评价和荟萃分析。
Blood Adv. 2022 Jan 11;6(1):62-71. doi: 10.1182/bloodadvances.2021005430.
8
Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients.在儿科患者 von Willebrand 病评估中重复检测的效用。
J Thromb Haemost. 2019 Nov;17(11):1838-1847. doi: 10.1111/jth.14591. Epub 2019 Aug 19.
9
Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.1 型血管性血友病患者出血倾向和抗出血治疗效果与血管性血友病因子清除率增加。
Thromb Haemost. 2011 Apr;105(4):647-54. doi: 10.1160/TH10-11-0697. Epub 2011 Jan 25.
10
CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.CLEC4M 和 STXBP5 基因突变可导致血管性血友病患者 von Willebrand 因子水平的变化。
J Thromb Haemost. 2015 Jun;13(6):956-66. doi: 10.1111/jth.12927. Epub 2015 May 9.

引用本文的文献

1
Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies.再次探讨 1 型血管性血友病的分类:来自 LoVIC 和 WiN 研究联合分析的新见解。
Blood. 2024 Apr 4;143(14):1414-1424. doi: 10.1182/blood.2023022457.

本文引用的文献

1
Low VWF: insights into pathogenesis, diagnosis, and clinical management.低血管性血友病因子:发病机制、诊断和临床管理的新见解。
Blood Adv. 2020 Jul 14;4(13):3191-3199. doi: 10.1182/bloodadvances.2020002038.
2
Pharmacologic intervention for the management of retained placenta: a systematic review and meta-analysis of randomized trials.药物干预治疗胎盘滞留:随机试验的系统评价和荟萃分析。
Am J Obstet Gynecol. 2020 Sep;223(3):447.e1-447.e19. doi: 10.1016/j.ajog.2020.06.044. Epub 2020 Jun 25.
3
New developments in von Willebrand disease.
血管性血友病的新进展。
Br J Haematol. 2020 Nov;191(3):329-339. doi: 10.1111/bjh.16681. Epub 2020 May 12.
4
Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies.采用现代当代方法对血管性血友病因子多聚体与活性进行比较评估。
Haemophilia. 2020 May;26(3):503-512. doi: 10.1111/hae.13957. Epub 2020 Mar 11.
5
What is an invasive procedure? A definition to inform study design, evidence synthesis and research tracking.什么是有创性操作?一个用于指导研究设计、证据综合和研究跟踪的定义。
BMJ Open. 2019 Jul 30;9(7):e028576. doi: 10.1136/bmjopen-2018-028576.
6
How I treat low von Willebrand factor levels.如何治疗低血管性血友病因子水平。
Blood. 2019 Feb 21;133(8):795-804. doi: 10.1182/blood-2018-10-844936. Epub 2018 Dec 21.
7
Von Willebrand disease in the United States: perspective from the Zimmerman program.美国的血管性血友病:齐默尔曼项目的视角
Ann Blood. 2018 Jan;3. doi: 10.21037/aob.2017.12.05. Epub 2018 Jan 26.
8
Significant gynecological bleeding in women with low von Willebrand factor levels.具有低血管性血友病因子水平的女性出现大量妇科出血。
Blood Adv. 2018 Jul 24;2(14):1784-1791. doi: 10.1182/bloodadvances.2018017418.
9
Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery.成人心脏手术后出血来源的荟萃分析。
J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1618-1624. doi: 10.1053/j.jvca.2017.12.024. Epub 2017 Dec 13.
10
Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.对低血管性血友病因子(VWF)水平潜在的临床表型和病理生理学的新见解。
Blood. 2017 Nov 23;130(21):2344-2353. doi: 10.1182/blood-2017-05-786699. Epub 2017 Sep 15.